Breaking News Instant updates and real-time market news.

BAC

Bank of America

$31.12

0.19 (0.61%)

, FB

Facebook

$186.68

-0.31 (-0.17%)

08:55
05/15/18
05/15
08:55
05/15/18
08:55

Notable open interest changes for May 15th

Monday's total option volume of 17.0 million contracts resulted in net open interest growth of 2.68 million calls and 2.72 million puts. Bank of America (BAC), Facebook (FB), Qualcomm (QCOM) and AMD (AMD) saw the greatest growth. Top five new positions opened include 38k Bank of America (BAC) May-18 32 calls, 26k Herbalife (HLF) Jan-19 25 puts, 25k JD.com (JD) Jun-18 38 calls, 25k Bank of America (BAC) 6/1 weekly 30 puts and 24k JD.com (JD) Jun-18 38 puts.

BAC

Bank of America

$31.12

0.19 (0.61%)

FB

Facebook

$186.68

-0.31 (-0.17%)

QCOM

Qualcomm

$56.73

1.51 (2.73%)

AMD

AMD

$12.22

0.27 (2.26%)

  • 15

    May

  • 15

    May

  • 30

    May

  • 03

    Jun

BAC Bank of America
$31.12

0.19 (0.61%)

01/31/18
DBAB
01/31/18
NO CHANGE
Target $15
DBAB
Sell
GE likely to be dropped from Dow 30 index, says Deutsche Bank
General Electric (GE) is likely to be dropped from the Dow Jones Industrial Average after being in the index of 30 companies for over 110 years as an original member since 1896, Deutsche Bank analyst John Inch tells investors in a research note. The chances that GE could be removed from the Dow are increasing as the company continues to face "substantial challenges," the analyst writes. These include "earnings and cash pressure, tough global power generation markets, aggressive downsizing, shrinking its portfolio, management shake-up and SEC investigations," Inch argues. He sees "headline risk" as the most significant risk factor if GE were to be dropped from the Dow, "potentially amplified by GE's high mix of retail investors." Inch notes that the last major Dow shakeup occurred in September 2003, when American Airlines (AAL), Bank of America (BAC) and Hewlett Packard (HPQ) were removed and Goldman Sachs (GS), Nike (NKE) and Verizon (VZ) were added. Inch has a Sell rating on General Electric with a $15 price target. The shares closed yesterday down 33c to $15.95.
04/17/18
BMOC
04/17/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America is the best of the 'big four' U.S. banks, says BMO Capital
BMO Capital analyst James Fotheringham kept his Market Perform rating and $34 price target on Bank of America (BAC) after its in-line Q1 earnings but raised his FY18 EPS view to $2.62 from $2.59 and FY19 view to $3.18 from $3.12. Fotheringham says than in contrast, he lowered earnings forecasts for JPMorgan (JPM), Wells Fargo (WFC), and Citigroup (C) because of higher costs and lower revenues, but Bank of America's better than expected net interest income rise justifies his view of the bank as the "best of the bunch". The analyst also notes the bank's more favorable valuation trading at a below-average two-year-forward P/E multiple despite his forecast of double the core earnings growth rate of Bank of America's peers.
04/03/18
BMOC
04/03/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America pullback provides a buying opportunity, says BMO Capital
BMO Capital analyst James Fotheringham says that the recent near-10% pullback in the Bank of America stock price provides investors with a buying opportunity. The analyst contends that the bank's stock trades much more closely in line with short term interest rates rather than the 10-year and believes that its net interest margins will prove to be "insensitive" to lower yields on the benchmark as well as higher LIBOR-OIS spreads. Fotheringham keeps his $34 price target and Market Perform rating on Bank of America, adding that its current two-year-forward P/E valuation multiple is close to its long-term historical average.
02/02/18
MSCO
02/02/18
NO CHANGE
MSCO
BofA, JPMorgan, Citi best positioned for tougher CCAR test, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck said she had expected an easier stress test from the Federal Reserve but that the 2018 CCAR test actually seems tougher than last year, given the more intense recessions and lower asset prices modeled in it. A tougher test makes her less optimistic on her strong payout growth expectations, said Graseck, who sees Bank of America (BAC), JPMorgan (JPM) and Citi (C) as best positioned to "weather the storm" and increase payouts given their resilient balance sheets and significant excess capital. She sees Goldman Sachs (GS), which recently cut buybacks, as at risk from a tougher test, which likely weighs on the bank's 2018 ask, Graseck added.
FB Facebook
$186.68

-0.31 (-0.17%)

05/11/18
BNCH
05/11/18
NO CHANGE
Target $182
BNCH
Buy
IAC price target raised to $182 from $176 at Benchmark
Benchmark analyst Daniel Kurnos raised his price target on IAC (IAC) to $182 from $176 after its "strong" quarter, which he said was "headlined by blowout revenue and earnings" from Match (MTCH) and continued strong growth at Angi Homeservices (ANGI). He believes risk to IAC from a Facebook (FB) dating challenge seems largely factored in at current levels, Kurnos added.
05/10/18
DBAB
05/10/18
NO CHANGE
Target $43
DBAB
Buy
Match Group price target raised to $43 from $33 at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley raised his price target for Match Group (MTCH) to $43 and keeps a Buy rating on the shares. The company's "strong" Q1 results were "overwhelmed' by concerns over Facebook (FB), Walmsley tells investors in a research note. He believes multiple expansion could remain challenged until investors have visibility into Facebook's product and adoption trends.
05/10/18
UBSW
05/10/18
UPGRADE
Target $48
UBSW
Buy
Match Group upgraded to Buy at UBS
As previously reported, UBS analyst Eric Sheridan upgraded Match Group (MTCH) to Buy from Neutral. The analyst said the recent risks and fears of competition from Facebook (FB) are priced in and its solid Q1 results show the trends for its core brands remain intact. Sheridan maintained his $48 price target on Match Group shares.
05/10/18
BMOC
05/10/18
NO CHANGE
Target $45
BMOC
Outperform
Match Group price target lowered to $45 from $49 at BMO Capital
BMO Capital analyst Daniel Salmon lowered his price target on Match Group (MTCH) to $45, citing the recent sell-off in the stock price after the Facebook (FB) announcement that it is entering into the online dating market. Salmon keeps his Outperform rating however, stating that the valuation discount is too great because he does not expect a "material disruption" to Tinder's use of the Facebook login. The analyst adds that 75% of Tinder users decline to login through Facebook, suggesting that people prefer to keep some space between their social and dating lives.
QCOM Qualcomm
$56.73

1.51 (2.73%)

05/03/18
05/03/18
UPGRADE
Target $127.5

Buy
NXP Semiconductors upgraded to Buy on deal closure optimism at Drexel Hamilton
As previously reported, Drexel Hamilton analyst Cody Acree upgraded NXP Semiconductors (NXPI) to Buy from Hold, citing his optimism about the company closing its merger with Qualcomm (QCOM). While still working to satisfy MOFCOM regulatory approval, NXP reported results that were largely in-line with his seasonal expectations and consistent with the positive industry trends being seen from most of the analog group, Acree tells investors. He raised his price target on NXP shares to $127.50 from $110.
04/26/18
BMOC
04/26/18
NO CHANGE
Target $55
BMOC
Market Perform
Qualcomm price target lowered to $55 from $70 at BMO Capital
BMO Capital analyst Tim Long lowered his price target on Qualcomm (QCOM) to $55 and kept his Market Perform rating. Long says that despite the "favorable" Q2 results, the company announced "much weaker" guidance for the June quarter, noting that while the chip business continues to deliver, the "outlook for royalties is negative". Aside from the ongoing disputes with Apple (AAPL) and Huawei, the analyst points to reduced royalty rates from other licensees, including a lower effective rate from Samsung (SSNLF). Long prefers a neutral stance amid the "ongoing uncertainty around licensing, as well as multiple regulatory investigations".
05/03/18
RHCO
05/03/18
NO CHANGE
Target $119
RHCO
Buy
NXP quarter does not confirm bear thesis, says SunTrust
SunTrust analyst William Stein says NXP Semiconductors' (NXPI) miss in Q1, while a bad print, does not confirm the bear thesis on the shares, which he believes centers around a "disengaged management team and a broken product portfolio." Despite the Q1 miss management remains engaged, and the product portfolio "remains robust," Stein tells investors in a post-earnings research note. He thinks management will only demonstrate engagement if the Qualcomm (QCOM) deal breaks. The analyst lowered his price target for NXP Semiconductors to $119 from $121 and keeps a Buy rating on the shares.
04/27/18
RHCO
04/27/18
UPGRADE
Target $121
RHCO
Buy
NXP Semiconductors upgraded to Buy at SunTrust on attractive price entry
As reported earlier, SunTrust analyst William Stein upgraded NXP Semiconductors (NXPI) to Buy, saying that the selloff from the re-filing by Qualcomm (QCOM) for its acquisition with China's Commerce Ministry has taken the stock to "compelling" levels. The analyst contends that even if the deal does not close, the company's stand-alone value is modeled at $121, implying an 18% return from the current level. Stein lowers his price target to $121 from $127.50 as part of his upgrade but sees the "bull case" scenario leading to $135 stock price .
AMD AMD
$12.22

0.27 (2.26%)

04/27/18
JEFF
04/27/18
NO CHANGE
Target $42
JEFF
Underperform
Intel model is 'showing signs of stress,' says Jefferies
Intel (INTC) beat and raised handily last night, but its model is "showing signs of stress," Jefferies analyst Mark Lipacis tells investors in a post-earnings research note titled "Nice Quarter - But Are There Cracks in the Facade?" He raised his price target for the shares to $42 from $38 but reiterates an Underperform rating on Intel, citing increasing capital expenditure intensity, free cash flow being well below earnings, delays in 10nm product ramp and process node transitions, declining gross margins, and increasing competition from Nvidia (NVDA) and AMD (AMD).
04/26/18
BARD
04/26/18
NO CHANGE
Target $20
BARD
Outperform
AMD blockchain and EPYC platform concerns overblown, says Baird
Baird analyst Tristan Gerra noted Advanced Micro Devices raised its revenue and growth expectations for the year following Q1 results. The analyst said the growth expectations are being driven by new products, while the blockchain-related mix is expected to remain stable. He also said the EPYC and Ryzen ramp continues and its 7nm migration signifies further share gains over time. Gerra reiterated his Outperform rating and $20 price target on Advanced Micro Devices shares.
04/26/18
JPMS
04/26/18
NO CHANGE
Target $13
JPMS
Neutral
AMD price target lowered to $13 from $16 at JPMorgan
JPMorgan analyst Harlan Sur lowered his price target for AMD to $13 following last night's Q1 results. The analyst expects the competitive front to remain challenging and believes AMD will need to "invest meaningfully" in engineering resources as it attempts to keep pace with the market leaders, which he notes is "dampening earnings power expansion." Sur keeps a Neutral rating on AMD shares.
04/27/18
MSCO
04/27/18
NO CHANGE
Target $54
MSCO
Equal Weight
Intel enterprise and data center comms strength surprising, says Morgan Stanley
Morgan Stanley analyst Joseph Moore noted that all three subsegments in Intel's (INTC) data center group were well above trend in Q1, calling the strength in cloud expected but the strength in enterprise and data center comms "surprising." Citing challenges to Intel's manufacturing position, including its 10 nm being pushed out for a second straight year, along with competitive threats from Nvidia (NVDA) and AMD (AMD), he maintains an Equal Weight rating on Intel shares. However, e Moore said he has clearly been too cautious and underappreciated how good the surge in cloud spending would be for Intel, raising his price target on the stock to $54 from $43.

TODAY'S FREE FLY STORIES

DAC

Danaos

$1.60

0.05 (3.23%)

16:52
09/24/18
09/24
16:52
09/24/18
16:52
Earnings
Danaos reports Q2 EPS 27c, one estimate 23c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AWK

American Water

$87.80

-0.8 (-0.90%)

16:46
09/24/18
09/24
16:46
09/24/18
16:46
Hot Stocks
American Water to spend $2M to upgrade water main in Missouri »

Missouri American Water…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

COLD

Americold Realty Trust

$25.25

-0.09 (-0.36%)

16:45
09/24/18
09/24
16:45
09/24/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Americold Realty Trust »

Senator Investment Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRNB

Principia Biopharma

$27.34

0.24 (0.89%)

16:45
09/24/18
09/24
16:45
09/24/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Principia Biopharma »

Cormorant Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DCPH

Deciphera

$39.80

0.78 (2.00%)

16:42
09/24/18
09/24
16:42
09/24/18
16:42
Initiation
Deciphera initiated  »

Deciphera initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Nov

BJ

BJ's Wholesale

$28.47

-0.68 (-2.33%)

16:42
09/24/18
09/24
16:42
09/24/18
16:42
Syndicate
BJ's Wholesale files to sell 28M shares of common stock for holders »

BofA Merrill Lynch,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

BPMC

Blueprint Medicines

$71.56

1.8 (2.58%)

16:41
09/24/18
09/24
16:41
09/24/18
16:41
Initiation
Blueprint Medicines initiated  »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGEN

Seattle Genetics

$78.57

0.53 (0.68%)

16:41
09/24/18
09/24
16:41
09/24/18
16:41
Initiation
Seattle Genetics initiated  »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOXO

Loxo Oncology

$163.07

3.91 (2.46%)

16:40
09/24/18
09/24
16:40
09/24/18
16:40
Initiation
Loxo Oncology initiated  »

Loxo Oncology initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 27

    Nov

INCY

Incyte

$66.48

-0.11 (-0.17%)

16:40
09/24/18
09/24
16:40
09/24/18
16:40
Initiation
Incyte initiated  »

Incyte initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AGIO

Agios Pharmaceuticals

$75.39

1.84 (2.50%)

16:40
09/24/18
09/24
16:40
09/24/18
16:40
Initiation
Agios Pharmaceuticals initiated  »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMLR

Semler Scientific

$0.00

(0.00%)

16:40
09/24/18
09/24
16:40
09/24/18
16:40
Hot Stocks
Breaking Hot Stocks news story on Semler Scientific »

Park West Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$32.63

0.22 (0.68%)

16:39
09/24/18
09/24
16:39
09/24/18
16:39
Initiation
Clovis initiated  »

Clovis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.09

-0.94 (-0.32%)

16:39
09/24/18
09/24
16:39
09/24/18
16:39
Periodicals
Trump inks revised trade pact with South Korea, CNBC says »

U.S. president Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.09

-0.94 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$36.41

-1.27 (-3.37%)

16:39
09/24/18
09/24
16:39
09/24/18
16:39
Initiation
Tesaro initiated  »

Tesaro initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

BGNE

BeiGene

$166.12

2.15 (1.31%)

16:38
09/24/18
09/24
16:38
09/24/18
16:38
Initiation
BeiGene initiated  »

BeiGene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 27

    Nov

BW

Babcock & Wilcox

$1.03

0.005 (0.49%)

16:38
09/24/18
09/24
16:38
09/24/18
16:38
Hot Stocks
Babcock & Wilcox to relocate Headquarters to Ohio »

Babcock & Wilcox…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAGX

Jaguar Health

$0.63

-0.022 (-3.37%)

16:37
09/24/18
09/24
16:37
09/24/18
16:37
Hot Stocks
Jaguar Health, Knight Therapeutics announce strategic partnership »

Knight Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HST

Host Hotels

$20.89

-0.23 (-1.09%)

, VNO

Vornado

$73.52

-1.58 (-2.10%)

16:36
09/24/18
09/24
16:36
09/24/18
16:36
Hot Stocks
Host Hotels sells New York Marriott Marquis Retail to Vornado for $442M »

Host Hotels & Resorts…

HST

Host Hotels

$20.89

-0.23 (-1.09%)

VNO

Vornado

$73.52

-1.58 (-2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CWEN

Clearway Energy

$19.85

-0.1 (-0.50%)

16:33
09/24/18
09/24
16:33
09/24/18
16:33
Syndicate
Clearway Energy announces offering of 3.92M shares of Class C common stock »

Clearway Energy …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIRK

Kirkland's

$9.30

-0.02 (-0.21%)

16:33
09/24/18
09/24
16:33
09/24/18
16:33
Hot Stocks
Kirkland's announces new $10M share repurchase program »

Kirkland's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUM

Summit Materials

$18.76

-0.285 (-1.50%)

16:32
09/24/18
09/24
16:32
09/24/18
16:32
Hot Stocks
Summit Materials sells GJP to Ferguson Waterworks, terms not stated »

Summit Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIRK

Kirkland's

$9.30

-0.02 (-0.21%)

16:32
09/24/18
09/24
16:32
09/24/18
16:32
Hot Stocks
Kirkland's names Steve Woodward as CEO, Mike Cairnes as COO »

Kirkland's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRE

Washington REIT

$30.60

-0.32 (-1.03%)

16:32
09/24/18
09/24
16:32
09/24/18
16:32
Periodicals
Washington REIT explores sale of retail portfolio, Bloomberg reports »

Washington REIT is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.09

-0.94 (-0.32%)

16:31
09/24/18
09/24
16:31
09/24/18
16:31
Periodicals
Trump says second meeting with Kim Jong Un likely 'quite soon,' AP says »

U.S. president Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.09

-0.94 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.